Literature DB >> 17215164

Effects of rosiglitazone and high fat diet on lipase/esterase expression in adipose tissue.

Wen-Jun Shen1, Shailja Patel, Zaixin Yu, Dyron Jue, Fredric B Kraemer.   

Abstract

A number of intracellular lipase/esterase have been reported in adipose tissue either by functional assays of activity or through proteomic analysis. In the current work, we have studied the relative expression level of 12 members of the lipase/esterase family that are found in white adipose tissue. We found that the relative mRNA levels of ATGL and HSL are the most abundant, being 2-3 fold greater than TGH or ADPN; whereas other intracellular neutral lipase/esterases were expressed at substantially lower levels. High fat feeding did not alter the mRNA expression levels of most lipase/esterases, but did reduce CGI-58 and WBSCR21. Likewise, rosiglitazone treatment did not alter the mRNA expression levels of most lipase/esterases, but did increase ATGL, TGH, CGI-58 and WBSCR21, while reducing ADPN. WAT from HSL-/- mice showed no compensatory increase in any lipase/esterases, rather mRNA levels of most lipase/esterases were reduced. In contrast, BAT from HSL-/- mice showed an increase in ATGL expression, as well as a decrease in ES-1, APEH and WBSCR21. Analysis of the immunoreactive protein levels of some of the lipases confirmed the results seen with mRNA. In conclusion, these data highlight the complexity of the regulation of the expression of intracellular neutral lipase/esterases involved in lipolysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17215164      PMCID: PMC1933526          DOI: 10.1016/j.bbalip.2006.11.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  46 in total

1.  Adiponutrin gene expression in 3T3-L1 adipocytes is downregulated by troglitazone.

Authors:  D Polson; M Thompson
Journal:  Horm Metab Res       Date:  2003-08       Impact factor: 2.936

2.  Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity.

Authors:  J Osuga; S Ishibashi; T Oka; H Yagyu; R Tozawa; A Fujimoto; F Shionoiri; N Yahagi; F B Kraemer; O Tsutsumi; N Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone.

Authors:  Steven M Watkins; Peter R Reifsnyder; Huei-ju Pan; J Bruce German; Edward H Leiter
Journal:  J Lipid Res       Date:  2002-11       Impact factor: 5.922

4.  Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome.

Authors:  C Lefèvre; F Jobard; F Caux; B Bouadjar; A Karaduman; R Heilig; H Lakhdar; A Wollenberg; J L Verret; J Weissenbach; M Ozgüc; M Lathrop; J F Prud'homme; J Fischer
Journal:  Am J Hum Genet       Date:  2001-10-02       Impact factor: 11.025

5.  Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects.

Authors:  V Large; S Reynisdottir; D Langin; K Fredby; M Klannemark; C Holm; P Arner
Journal:  J Lipid Res       Date:  1999-11       Impact factor: 5.922

Review 6.  PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?

Authors:  T M Larsen; S Toubro; A Astrup
Journal:  Int J Obes Relat Metab Disord       Date:  2003-02

7.  The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance.

Authors:  T Yamauchi; J Kamon; H Waki; K Murakami; K Motojima; K Komeda; T Ide; N Kubota; Y Terauchi; K Tobe; H Miki; A Tsuchida; Y Akanuma; R Nagai; S Kimura; T Kadowaki
Journal:  J Biol Chem       Date:  2001-08-31       Impact factor: 5.157

8.  Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-gamma.

Authors:  Haruaki Kageyama; Tsutomu Hirano; Kenta Okada; Tetsu Ebara; Asako Kageyama; Toru Murakami; Seiji Shioda; Mitsuru Adachi
Journal:  Biochem Biophys Res Commun       Date:  2003-05-23       Impact factor: 3.575

9.  Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice.

Authors:  Kenji Harada; Wen-Jun Shen; Shailja Patel; Vanita Natu; Jining Wang; Jun-ichi Osuga; Shun Ishibashi; Fredric B Kraemer
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-09-03       Impact factor: 4.310

10.  Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation.

Authors:  Carole Sztalryd; Guoheng Xu; Heidi Dorward; John T Tansey; Juan A Contreras; Alan R Kimmel; Constantine Londos
Journal:  J Cell Biol       Date:  2003-06-16       Impact factor: 10.539

View more
  18 in total

1.  Ablation of vimentin results in defective steroidogenesis.

Authors:  Wen-Jun Shen; Syed Kashif Zaidi; Shailja Patel; Yuan Cortez; Masami Ueno; Rakia Azhar; Salman Azhar; Fredric B Kraemer
Journal:  Endocrinology       Date:  2012-04-24       Impact factor: 4.736

2.  Quantification of lipid droplets and associated proteins in cellular models of obesity via high-content/high-throughput microscopy and automated image analysis.

Authors:  Patrick M McDonough; Ramses M Agustin; Randall S Ingermanson; Patricia A Loy; Benjamin M Buehrer; James B Nicoll; Natalie L Prigozhina; Ivana Mikic; Jeffrey H Price
Journal:  Assay Drug Dev Technol       Date:  2009-10       Impact factor: 1.738

3.  DHA regulates lipogenesis and lipolysis genes in mice adipose and liver.

Authors:  Chao Sun; Zhou-wen Wei; Yan Li
Journal:  Mol Biol Rep       Date:  2010-04-11       Impact factor: 2.316

4.  Adipose triglyceride lipase expression in human adipose tissue and muscle. Role in insulin resistance and response to training and pioglitazone.

Authors:  Aiwei Yao-Borengasser; Vijayalakshmi Varma; Robert H Coker; Gouri Ranganathan; Bounleut Phanavanh; Neda Rasouli; Philip A Kern
Journal:  Metabolism       Date:  2010-12-03       Impact factor: 8.694

5.  Vimentin is a functional partner of hormone sensitive lipase and facilitates lipolysis.

Authors:  Wen-Jun Shen; Shailja Patel; John E Eriksson; Fredric B Kraemer
Journal:  J Proteome Res       Date:  2010-04-05       Impact factor: 4.466

6.  Isoflavones enhance pharmacokinetic exposure of active lovastatin acid via the upregulation of carboxylesterase in high-fat diet mice after oral administration of Xuezhikang capsules.

Authors:  Dong Feng; Chun Ge; Zhao-Yi Tan; Jian-Guo Sun; Yuan Xie; Lan Yao; Cai-Xia Yan; Ji-Ye Aa; Guang-Ji Wang
Journal:  Acta Pharmacol Sin       Date:  2018-06-19       Impact factor: 6.150

Review 7.  Mammalian alpha beta hydrolase domain (ABHD) proteins: Lipid metabolizing enzymes at the interface of cell signaling and energy metabolism.

Authors:  Caleb C Lord; Gwynneth Thomas; J Mark Brown
Journal:  Biochim Biophys Acta       Date:  2013-01-14

8.  Adipose triglyceride lipase (ATGL) clone, expression pattern, and regulation by different lipid sources and lipid levels in large yellow croaker (Pseudosciaena crocea R.).

Authors:  Xinxia Wang; Yizhen Wang; Yongjin Li
Journal:  Mar Biotechnol (NY)       Date:  2012-07-27       Impact factor: 3.619

9.  Regulation of adipose triglyceride lipase by rosiglitazone.

Authors:  L-F Liu; A Purushotham; A A Wendel; K Koba; J DeIuliis; K Lee; M A Belury
Journal:  Diabetes Obes Metab       Date:  2008-07-17       Impact factor: 6.577

10.  Macrophage CGI-58 deficiency activates ROS-inflammasome pathway to promote insulin resistance in mice.

Authors:  Hongming Miao; Juanjuan Ou; Yinyan Ma; Feng Guo; Zhenggang Yang; Melvin Wiggins; Chaohong Liu; Wenxia Song; Xianlin Han; Miao Wang; Qiang Cao; Bik-Ho Florence Chung; Dan Yang; Houjie Liang; Bingzhong Xue; Hang Shi; Lixia Gan; Liqing Yu
Journal:  Cell Rep       Date:  2014-04-03       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.